VEGFA and central nervous system cancer: Another intriguing report details a screen for immune mutations in response to anti-VEGF treatment in GL261 and KR158B murine glioma lines that revealed a dose-dependent upregulation of immunosuppressive regulatory T-cell genes in response to anti-VEGF (159).